NCT01030913View on ClinicalTrials.gov

B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression

CompletedOBSERVATIONAL

Enrollment

1,248

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions

Chronic Lymphocytic Leukemia

Trial Locations (1)

11030

Feinstein Institute for Medical research, Manhasset

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

lead

Northwell Health

OTHER